NEJM Editorial Fellow Sarah Gorey, MD, summarizes the Original Article “Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.” Read the full article: https://nej.md/4kS5ZVr #ACC25 | The New England Journal of Medicine
2:14
NEJM Editorial Fellow Sarah Gorey, MD, summarizes the Original Article “Global Effect of Cardiovascular Risk Factors on Lifetime Estimates.” Read the full article: https://nej.md/4kS5ZVr #ACC25 | The New England Journal of Medicine
4.9K viewsApr 3, 2025
FacebookThe New England Journal of Medicine
NEJM Editorial Fellow Harleen K. Marwah, MD, breaks down new data on progression-free survival, overall survival, and safety from the BREAKWATER phase 3 trial in this 60-Second Journal Club. Read the full trial results: https://nej.md/3ScDaWC | The New England Journal of Medicine
2:20
NEJM Editorial Fellow Harleen K. Marwah, MD, breaks down new data on progression-free survival, overall survival, and safety from the BREAKWATER phase 3 trial in this 60-Second Journal Club. Read the full trial results: https://nej.md/3ScDaWC | The New England Journal of Medicine
4.1K views10 months ago
FacebookThe New England Journal of Medicine
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the Advance-HTN phase 2b trial, which investigated the aldosterone synthase inhibitor lorundrostat for uncontrolled hypertension. Full trial results: https://nej.md/4ipbCIf | The New England Journal of Medicine
1:52
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the Advance-HTN phase 2b trial, which investigated the aldosterone synthase inhibitor lorundrostat for uncontrolled hypertension. Full trial results: https://nej.md/4ipbCIf | The New England Journal of Medicine
4.3K viewsApr 25, 2025
FacebookThe New England Journal of Medicine
In this 60-Second Journal Club, NEJM Editorial Fellow Sarah Gorey, MB, summarizes the REDOX trial assessing hospitalization and mortality among patients with chronic severe hypoxemia who received long-term oxygen therapy for either 24 or 15 hours per day. Full trial results: https://nej.md/4cR3pK4 | The New England Journal of Medicine
1:26
In this 60-Second Journal Club, NEJM Editorial Fellow Sarah Gorey, MB, summarizes the REDOX trial assessing hospitalization and mortality among patients with chronic severe hypoxemia who received long-term oxygen therapy for either 24 or 15 hours per day. Full trial results: https://nej.md/4cR3pK4 | The New England Journal of Medicine
5.4K viewsFeb 4, 2025
FacebookThe New England Journal of Medicine
Check out the latest NEJM Quick Take about genetic testing and prostate cancer. | The New England Journal of Medicine
1:33
Check out the latest NEJM Quick Take about genetic testing and prostate cancer. | The New England Journal of Medicine
24 viewsNov 3, 2015
FacebookThe New England Journal of Medicine
This Stats, STAT! animated video from NEJM Evidence explores factorial designs in clinical trials. Factorial designs can improve the efficiency of trials but introduce unique considerations, such as the possibility of interactions, to the analysis of trial data. 📊✨ Full video in comments. | The New England Journal of Medicine
0:41
This Stats, STAT! animated video from NEJM Evidence explores factorial designs in clinical trials. Factorial designs can improve the efficiency of trials but introduce unique considerations, such as the possibility of interactions, to the analysis of trial data. 📊✨ Full video in comments. | The New England Journal of Medicine
2.1K viewsOct 15, 2024
FacebookThe New England Journal of Medicine
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the FINEARTS-HF trial examining the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction. Full trial results: https://nej.md/470x4ix | The New England Journal of Medicine
1:10
NEJM Editorial Fellow Christos Kotanidis, MD, DPhil, summarizes the FINEARTS-HF trial examining the efficacy and safety of finerenone in patients with heart failure with mildly reduced or preserved ejection fraction. Full trial results: https://nej.md/470x4ix | The New England Journal of Medicine
3K viewsFeb 20, 2025
FacebookThe New England Journal of Medicine
0:58
This Stats, STAT! animated video from NEJM Evidence explores the concept of treatment effect heterogeneity — and sheds light on what we can learn from the dinosaurs that survived an asteroid strike 66 million years ago. Watch the full video: https://youtu.be/oqXLqc4oxUM | The New England Journal of Medicine
1.7K viewsMar 19, 2024
FacebookThe New England Journal of Medicine
1:12
NEJM Wrapped 2025 is here. Take a look back at the numbers that went into a year of publishing at the world’s leading medical journal. To discover the 15 articles NEJM editors selected as among the most impactful in advancing clinical practice and patient care this year, download the Notable Articles of 2025: https://nej.md/4peY19S | The New England Journal of Medicine
2.3K views4 months ago
FacebookThe New England Journal of Medicine
1:57
What is it like to be an NEJM editorial fellow for a year? This year’s fellows — Drs. Abarna Pearl, Sarah Gorey, Christos Kotanidis, and Harleen Marwah — discuss what they have learned, how their experience will help their career, and what surprised them. Applications for the 2026–27 NEJM editorial fellowship are now open. NEJM will accept applications for several one-year, full-time, paid editorial fellowships that begin July 2026. Deadline is Friday, August 1, 2025. To learn more and to apply,
3K views11 months ago
FacebookThe New England Journal of Medicine
1:39
NEJM Editorial Fellow Abarna Pearl, MD, MPH, summarizes the ALPACA trial. Read the full trial results: https://nej.md/4kWjJyn | The New England Journal of Medicine
4.4K viewsApr 2, 2025
FacebookThe New England Journal of Medicine
5:26
NEJM editors explain new requirement, effective January 1, 2022, that clinical trial authors describe the representativeness of study participants. Read the editorial: https://nej.md/3jQw9dt | The New England Journal of Medicine
5.6K viewsSep 13, 2021
FacebookThe New England Journal of Medicine
1:05
Weight Regain after Stopping Obesity Medications: NEJM Clinician Editor-in-Chief Raja-Elie Abdulnour, MD, explains a recent meta-analysis that showed projected return to baseline weight within 2 years. | The New England Journal of Medicine
56.1K views2 months ago
FacebookThe New England Journal of Medicine
0:08
Coronary Angiography | NEJM
813.9K viewsSep 6, 2017
YouTubeNEJM Group
18:42
Introduction to Medical Statistics
160.2K viewsNov 5, 2012
YouTubeRanga Lingham
2:40
How Statistics is Changing Healthcare
10.7K viewsOct 26, 2020
YouTubeThis is Statistics
10:06
Medical Statistics - Part 8: Study Types in Medical Research
40.2K viewsNov 26, 2019
YouTubeAMBOSS: Medical Knowledge Distilled
8:25
Medical Statistics - Part 10: Type 1 and Type 2 Errors
18.9K viewsJul 8, 2021
YouTubeAMBOSS: Medical Knowledge Distilled
2:23
Explore the features of NEJM.org
3.1K viewsAug 18, 2021
YouTubeNEJM Group
17:35
Measles | NEJM
33.4K views4 months ago
YouTubeNEJM Group
11:52
Tickborne Diseases | NEJM
39K viewsMar 29, 2023
YouTubeNEJM Group
1:41
Introducing NEJM Clinician
766 views5 months ago
YouTubeNEJM Group
0:35
Happy New Year from NEJM Clinician
2.5K views4 months ago
YouTubeNEJM Group
22:55
NEJM This Week — March 5, 2026
7.5K views2 months ago
YouTubeNEJM Group
5:27
Large Language Models | NEJM Evidence
4.1K viewsJul 28, 2023
YouTubeNEJM Group
5:03
How Factorial Design Works | NEJM Evidence
25.1K viewsAug 29, 2024
YouTubeNEJM Group
15:00
What Is Rheumatoid Arthritis? | NEJM
71.2K viewsApr 3, 2024
YouTubeNEJM Group
5:20
How Censoring Works | NEJM Evidence
8.2K viewsSep 29, 2023
YouTubeNEJM Group
13:35
Human Papillomavirus and Cancer | NEJM
34.4K views9 months ago
YouTubeNEJM Group
5:25
How Meta-Analysis Works | NEJM Evidence
11.6K viewsJul 1, 2024
YouTubeNEJM Group
See more